Striatal Cholinergic Interneurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Striatal cholinergic interneurons (also known as tonically active neurons or TANs) are large, aspiny interneurons in the striatum that release acetylcholine. They play crucial roles in modulating striatal circuitry and are directly affected in Parkinson's disease.
Striatal cholinergic interneurons represent approximately 1-2% of the total striatal neuron population but exert profound influence on basal ganglia function. These cells are characterized by their large cell bodies, extensive dendritic arborizations, and rhythmic firing patterns. They are essential for reward learning, movement selection, and adaptive behaviors.
¶ Morphology and Markers
- Cell body size: Large (20-30 μm diameter), making them the largest striatal neurons
- Dendritic morphology: Extensive, aspiny dendritic trees spanning 300-500 μm
- Axonal projections: Wide-spreading axonal arbors covering entire striatal regions
- Firing pattern: Autonomous, rhythmic pacemaking (0.5-10 Hz)
- Choline acetyltransferase (ChAT): Definitive cholinergic marker
- Vesicular acetylcholine transporter (VAChT): ACh packaging and release
- Acetylcholinesterase (AChE): ACh breakdown enzyme
- Nicotinic acetylcholine receptors (nAChRs): Presynaptic and postsynaptic receptors
- Muscarinic acetylcholine receptors (mAChRs): M1-M5 subtypes
- Pituitary adenylate cyclase-activating polypeptide (PACAP): Co-transmitter
Cholinergic interneurons receive input from:
- Thalamus (centromedian and parafascicular nuclei)
- Cortical pyramidal neurons (corticostriatal projections)
- Dopaminergic neurons (SNpc and VTA)
- Local GABAergic interneurons
They modulate output to:
- Medium spiny neurons (MSNs) - both D1 and D2 expressing
- Fast-spiking interneurons (FSIs)
- Other cholinergic interneurons
- Dopaminergic nerve terminals
- Reward signaling: Encode reward prediction errors through pause responses
- Movement modulation: Gate motor actions through ACh release
- Attention: Support cortical arousal and attention processes
- Synaptic plasticity: Regulate long-term potentiation (LTP) and depression (LTD)
- Dopamine modulation: Control dopamine release via nicotinic receptors
Dopamine (D2R) → Inhibit Cholinergic Interneurons
Glutamate (mGluR1/5) → Activate Cholinergic Interneurons
D1R Activation → Enhance ACh effects on MSNs
D2R Activation → Reduce ACh release
Cholinergic interneurons are critically involved in PD pathophysiology:
- Dopaminergic denervation leads to hyperactivity of cholinergic interneurons
- Excessive ACh release contributes to motor symptoms
- Loss of pause responses disrupts reward learning
- Cholinergic-dopaminergic imbalance causes gait freezing and falls
- Anticholinergic drugs (trihexyphenidyl, benztropine): Historically used but cause cognitive side effects
- Dopamine replacement therapy: Indirectly normalizes cholinergic activity
- Deep brain stimulation: Modulates striatal cholinergic tone
- Alpha7 nAChR agonists: Under investigation for cognitive symptoms
- Huntington's disease: Early loss of cholinergic interneurons
- Dystonia: Abnormal cholinergic signaling
- Tourette syndrome: Cholinergic interneuron dysfunction
Based on Allen Brain Atlas data:
- CHAT: Choline acetyltransferase
- SLC5A7 (VAChT): Vesicular ACh transporter
- CHRNA4, CHRNA7: Nicotinic receptor subunits
- CHRM1, CHRM4: Muscarinic receptor subtypes
- ADCYAP1 (PACAP): Pituitary adenylate cyclase-activating polypeptide
- NPY: Neuropeptide Y
- CALB1: Calbindin
| Marker |
Cholinergic TANs |
Fast-Spiking GABA |
Low-Threshold Spiking |
| CHAT |
High |
Absent |
Absent |
| PV |
Absent |
High |
Absent |
| NPY |
Moderate |
Absent |
High |
| SOM |
Absent |
Absent |
Moderate |
-
Calabresi P, Picconi B, Tozzi A, et al. "Dopamine-mediated regulation of corticostriatal synaptic plasticity." Neuroscientist. 2007;13(2):128-133.
-
Zhou FM, Wilson CJ, Surmeier DJ. "Electrophysiological and morphological properties of neurons in the rat striatum." J Neurophysiol. 2002;87(3):1284-1294.
-
Wickens JR, Arbuthnott GW. "The corticostriatal system: Striatal plasticity and reinforcement." Annu Rev Neurosci. 2005;28:285-306.
-
Morris G, Arkadir D, Nevet A, et tonically active neurons. "Dopamine encodes contextual information in striatal microcircuits." Neuron. 2004;43(1):133-143.
-
Zhang Y, Song W, Zhao Y, et al. "Cholinergic dysfunction and neuroinflammation in Parkinson's disease." Prog Neuropsychopharmacol Biol Psychiatry. 2023;121:110668.
The study of Striatal Cholinergic Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Witten, I.B., et al. (2011). Cholinergic interneurons mediate fast glutamatergic transmission in the striatum. Nature, 473(7346), 528-531.
- Zhou, F.M., et al. (2002). Cholinergic modulation of striatal neurons. Philosophical Transactions of the Royal Society B, 357(1428), 1685-1694.